Podcast Episode Details

Back to Podcast Episodes
Our Biggest Questions About Chelsea Heading Into The 25/26 Season, Levi Colwill's ACL Surgery & Nicolas Jackson To Newcastle For £80m? #CFC

Our Biggest Questions About Chelsea Heading Into The 25/26 Season, Levi Colwill's ACL Surgery & Nicolas Jackson To Newcastle For £80m? #CFC


Episode 525


In this episode, the team are joined by Jéssica Frota as they dive into the biggest questions surrounding Chelsea FC ahead of the 2025/26 season.

How will the Blues handle such a short rest between the Club World Cup and Pre-Season? Can new signings like Jorrel Hato, Liam Delap and Joao Pedro make a significant impact?


The team also talk the latest from this week's news and as always also answer some listener questions.


RUNNING ORDER:

00:00 The Start, Shevva's Shoutouts & Why The Club World Cup Really Is Special

22:05 News: Nicolas Jackson To Newcastle For £80m?, Levi Colwill & Alejandro Garnacho

29:48 Our Biggest Questions About Chelsea Heading Into The 25/26 Season

57:00 BREAKING NEWS: Levi Colwill Out For The Majority Of The 2025/26 Season

1:14:02 Bayer Leverkusen & AC Milan Preview


If you have a question for the team then contact them on Twitter at @AtTheBridgePod


(This episode was recorded on 7th August 2025)


*** Please take the time to rate and review us on Apple Podcasts or wherever you get your pods. It means a great deal to the show and will make it easier for other potential listeners to find us. Thanks!

*** Join our Discord: https://discord.gg/b3arBztQjn


This episode is proudly supported by Head In The Game, a charity using football to support mental health and wellbeing. Check out their free programs at headinthegame.co.uk and follow them on social media to learn more.

_______________________________________________

Get In Touch With Us:

Twitter - twitter.com/AtTheBridgePod

Instagram - Instagram.com/AtTheBridgePod

#CFC #CHELSEA


Published on 4 months, 2 weeks ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate